Zelda Therapeutics well-funded to advance cannabinoid treatments for medical conditions

Zelda Therapeutics Ltd (ASX:ZLD) (OTCQB:ZLDAF) is well funded to make strong progress in 2018 with the development of cannabinoid -based formulations for the treatment of a variety of medical conditions. The company’s cash at bank was $6.61 million at 31 December 2017 and it is fully funded for …

Read More

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.